Results 121 to 130 of about 2,363,590 (195)

Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century. [PDF]

J Diabetes Sci Technol, 2009
Sherman RA.
europepmc   +1 more source

Oral myiasis complicating endotracheal intubation in a diabetic patient: a case report. [PDF]

Front Endocrinol (Lausanne)
Xiao Q, Zhao Y, Du J, Wang Y, Tang Q, Liang Z.   +5 more
europepmc   +1 more source

Maggot therapy revisited.

The Western journal of medicine, 1985
J, Bunkis, S, Gherini, R L, Walton
openaire   +1 more source

Procedures for determining the antimicrobial activity of maggot excretions and secretions of the green bottle fly: a narrative literature review. [PDF]

Braz J Med Biol Res
Dallavecchia DL, Lima E Silva AA, Debelian ACM, Aguiar VM, Silva Filho RG.   +4 more
europepmc   +1 more source

Ultrasonographic features of <i>Lucilia sericata</i>-induced wound myiasis with foot gas gangrene: A case report. [PDF]

Radiol Case Rep
Munekata Y, Kawamura T, Nishikawa J, Tennoji T, Ogino Y, Aonuma H, Takahashi Y.   +6 more
europepmc   +1 more source

Challenge to Eliminate Parasite Palatal Infestation in a Deaf-Mute Geriatric Patient. [PDF]

Case Rep Dent
Pranoto AE, Runting N.
europepmc   +1 more source

Comparative effectiveness of debridement strategies for chronic lower-extremity wounds: a systematic review and network meta-analysis. [PDF]

Front Med (Lausanne)
Li G, Zhang X, Liu S, Chen L, Liu S.
europepmc   +1 more source

Eat and heal. Past, present and future of maggot debridement therapy: a narrative review. [PDF]

Infez Med
Simonetti O, Zerbato V, Bellinato F, Cavalli F, Armocida E, Luzzati R, Di Bella S.   +6 more
europepmc   +1 more source

Post-traumatic cerebral myiasis: the first case report in Ghana and implications for neurotrauma care in low-resource settings. [PDF]

Ann Med Surg (Lond)
Agyekum R, Gyebi EAA, Kwadwo D, Anati A, Harley BB, Andani AD.   +5 more
europepmc   +1 more source

Correction: Ban-Cucerzan et al. Bovine Mastitis Therapy at a Crossroads: Pharmacokinetic Barriers, Biofilms, Antimicrobial Resistance, and Emerging Solutions. <i>Pharmaceuticals</i> 2026, <i>19</i>, 175. [PDF]

Pharmaceuticals (Basel)
Ban-Cucerzan A, Morar A, Tîrziu E, Bucur IM, Popa SA, Imre K.   +5 more
europepmc   +1 more source